The Cancer Genome Atlas (TCGA) classifies endometrial cancer into four molecular subtypes: (1) POLE ultra-mutated, (2) Microsatellite unstable, (3) Abnormal p53 expression (p53 Abn) and (4) No specific molecular profile (NSMP), forming the basis of the Proactive...
This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during September 2025 (epidemiological weeks 36-39). The data is dependent on submission of samples by clinicians and therefore may not be...
Laboratory-based data for all GIT molecular panels requested for patients at PathCare laboratories nationally, for the period June to August 2025, are presented in this report. The trends observed for major bacterial and viral pathogens detected from stool samples of...
Linezolid, a synthetic oxazolidinone antibiotic, is frequently used for the treatment of serious gram-positive infections including Staphylococcus aureus and enterococci. It is also commonly used as part of long-term treatment regimens for mycobacterial infections,...
This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during August 2025 (epidemiological weeks 32-35). The data is dependent on submission of samples by clinicians and therefore may not be...
As we continue further into the multidrug resistant era, it becomes necessary to develop a deeper understanding of how to perform and interpret antimicrobial susceptibility testing. The clinical microbiology laboratory provides valuable susceptibility data that can...
PathCare introduces Xpert MTB/XDR testing as a reflex test for rapid molecular drug susceptibility testing of rifampicin-resistant Mycobacterium tuberculosis (RR-TB) positive clinical samples South Africa remains one of the top 30 high-burden countries for...
This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during July 2025 (epidemiological weeks 27-31). The data is dependent on submission of samples by clinicians and therefore may not be...
We are pleased to announce an important enhancement to our endocrine diagnostics service. As of 29 July 2025, our laboratory will transition from reporting urine total (deconjugated) metanephrines (currently performed via HPLC) to urine free (unconjugated)...
This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare Laboratories during June 2025.Respiratory Pathogen Statistics June 2025